Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Dier Mardi
Relationship:  
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   101,126    

Indirect Shares

   875      
Direct Value   $4,730,138    

Indirect Value

   $4,148      
Total Shares   102,001      
Total Value   $4,734,285      


Adamas Pharmaceuticals Inc $82,200 Prelude Therapeutics Inc $0 Ultragenyx Pharmaceutical Inc $2,742,498 Acelyrin, Inc. $26,335 Madrigal Pharmaceuticals Inc $1,879,104 Adamas Pharmaceuticals Inc $82,200 Prelude Therapeutics Inc $0 Ultragenyx Pharmaceutical Inc $2,742,498 Acelyrin, Inc. $26,335 Madrigal Pharmaceuticals Inc $1,879,104
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    0   
    1    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   -2.0   
   1.0   
     Percentage Gain/Loss :
   -71.0%
 18.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Portola Pharmaceuticals Inc PTLA EVP and CFO 2020-07-02 0 0    Premium*  
            Adamas Pharmaceuticals Inc ADMS Director 2021-06-02 10,000 2020-06-03 0    Premium*  
            Prelude Therapeutics Inc PRLD Director 2020-09-29 10,000 2020-09-29 0    Premium*  
            Ultragenyx Pharmaceutical Inc RARE CFO & Executive Vice P... 2022-10-14 66,695 2020-10-12 0    Premium*  
            Acelyrin, Inc. SLRN CFO and CBO 2023-05-09 5,556 2023-05-09 875    Premium*  
            Madrigal Pharmaceuticals Inc MDGL 2024-03-11 8,875 0    Premium*  
* Premium Members only  

Records found :    73         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-11-25 4 AS $28.23 $31,561 D/D (1,118) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-02-23 4 AS $39.95 $227,395 D/D (5,692) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-05-11 4 S $38.21 $522,511 D/D (13,674) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-05-12 4 S $37.88 $503,452 D/D (13,290) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-05-27 4 AS $41.00 $249,116 D/D (6,076) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-06-08 4 AS $43.00 $693,117 D/D (16,119) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-09-18 4 AS $55.00 $490,160 D/D (8,912) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-03-15 4 AS $40.02 $409,605 D/D (10,235) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-06-27 4 AS $54.94 $5,179,825 D/D (93,392) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-07-11 4 AS $60.00 $1,401,000 D/D (23,350) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-08-16 4 D $54.86 $199,416 D/D (3,635) 0 0 -
PTLA Portola Pharmaceuticals I... EVP and CFO   •       –      –    2020-07-02 4 D $18.00 $712,314 D/D (39,573) 0 0 -
PTLA Portola Pharmaceuticals I... EVP and CFO   •       –      –    2020-06-18 4 A $8.36 $84 D/D 10 10 0 -
SLRN Acelyrin, Inc. CFO and CBO   •       –      –    2023-05-09 4 B $18.00 $31,500 I/I 1,750 875 1.99 %
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-08-25 4 AS $25.72 $131,314 D/D (5,000) 1,118 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-03-15 4 OE $7.00 $78,095 D/D 10,235 4,300 0 -
ADMS Adamas Pharmaceuticals In... Director   –       •      –    2020-06-03 4 A $0.00 $0 D/D 5,000 5,000 0 -
SLRN Acelyrin, Inc. CFO and CBO   •       –      –    2023-05-09 4 B $18.00 $100,008 D/D 5,556 5,556 2.74 %
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-02-23 4 OE $4.10 $25,351 D/D 5,692 5,692 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-05-27 4 OE $5.00 $30,380 D/D 6,076 6,076 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-07-25 4 AS $24.11 $120,568 D/D (5,000) 6,118 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-06-27 4 OE $7.00 $1,736,009 D/D 93,392 6,885 0 -
MDGL Madrigal Pharmaceuticals ... SVP and CFO   •       –      –    2024-03-11 3 IO $0.00 $0 D/D 0 8,875 %
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-09-18 4 OE $5.10 $64,951 D/D 8,912 8,912 0 -
PRLD Prelude Therapeutics Inc Director   –       •      –    2020-09-29 4 B $19.00 $190,000 D/D 10,000 10,000 2.39 -
  73  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us